Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting CD24/CTNNB1/SOX4-Centered Signaling Hub
- Jing Wen Shih
- , Alexander T.H. Wu
- , Ntlotlang Mokgautsi
- , Po Li Wei
- , Yan Jiun Huang
- Master Program in Graduate Institute of Cancer Biology and Drug Discovery
- The Ph.D. Program for Translational Medicine
- TMU Research Center of Cancer Translational Medicine
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery
- Taipei Heart Institute (THI), Taipei Medical University
- International Ph.D. Program for Translational Science
- Graduate Institute of Biomedical Informatics
- International Ph.D. Program in Cell Therapy and Regenerative Medicine
- TMU Research Center for Digestive Medicine
- Taipei Medical University Hospital
- Master Program in Clinical Genomics and Proteomics
- Graduate Institute of Clinical Medicine
- Division of Colorectal surgery
- International Master Program for Translational Science
Research output: Contribution to journal › Article › peer-review
11
Link opens in a new tab
Citations
(Scopus)